Fumiko Oda

Chiba, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Cerebello-brainstem dominant form of adrenoleukodystrophy with neurological symptom onset triggered by COVID-19.

Cerebello-brainstem dominant form of adrenoleukodystrophy with neurological symptom onset triggered by COVID-19.

Journal: Journal of the neurological sciences

Published: January 06, 2025

Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathy.

Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathy.

Journal: Journal of neuroimmunology

Published: June 12, 2021

Marked Respiratory Failure in an Ambulant Patient with Immune-mediated Necrotizing Myopathy and Anti-Kv1.4 and Anti-titin Antibodies.

Marked Respiratory Failure in an Ambulant Patient with Immune-mediated Necrotizing Myopathy and Anti-Kv1.4 and Anti-titin Antibodies.

Journal: Internal medicine (Tokyo, Japan)

Published: March 01, 2021

Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2.

Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2.

Journal: Annals of neurology

Published: January 14, 2021

Long-term outcomes and prognostic factors in generalized myasthenia gravis.

Long-term outcomes and prognostic factors in generalized myasthenia gravis.

Journal: Journal of neurology

Published: December 08, 2020

Intrathymic Plasmablasts Are Affected in Patients With Myasthenia Gravis With Active Disease.

Intrathymic Plasmablasts Are Affected in Patients With Myasthenia Gravis With Active Disease.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: September 23, 2020

Changes in serum complements and their regulators in generalized myasthenia gravis.

Changes in serum complements and their regulators in generalized myasthenia gravis.

Journal: European journal of neurology

Published: June 03, 2020

Increased serum acetylcholine receptor α1 subunit protein in anti-acetylcholine receptor antibody-positive myasthenia gravis.

Increased serum acetylcholine receptor α1 subunit protein in anti-acetylcholine receptor antibody-positive myasthenia gravis.

Journal: Journal of neuroimmunology

Published: November 20, 2019

Safety of tapering tacrolimus dose in patients with well-controlled anti-acetylcholine receptor antibody-positive myasthenia gravis.

Safety of tapering tacrolimus dose in patients with well-controlled anti-acetylcholine receptor antibody-positive myasthenia gravis.

Journal: European journal of neurology

Published: April 01, 2019

Frequency and features of myasthenia gravis developing after thymectomy.

Frequency and features of myasthenia gravis developing after thymectomy.

Journal: European journal of neurology

Published: March 29, 2019

Efficacy of high-dose intravenous methylprednisolone therapy for ocular myasthenia gravis.

Efficacy of high-dose intravenous methylprednisolone therapy for ocular myasthenia gravis.

Journal: Journal of the neurological sciences

Published: March 10, 2019

Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis.

Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis.

Journal: Journal of the neurological sciences

Published: March 10, 2018

Showing 1-12 of 18

Last Updated: 09/26/2026